Brazilian Network for HIV Drug Resistance Surveillance: A survey of individuals recently diagnosed with HIV

Journal of the International AIDS Society

Volumn 12, Issue 1, 2009, Pages

  Inocencio, Lilian A ^a   Pereira, Anderson A ^a   Sucupira, Maria Cecilia A ^b   Fernandez, José Carlos C ^c   Jorge, Célia P ^d   Souza, Denise F C ^a   Fink, Helena T ^e   Diaz, Ricardo S ^b   Becker, Irina M ^f   Suffert, Theodoro A ^g   Arruda, Monica B ^h   MacEdo, Olinda ^h   Simão, Mariangela B G ^a   Tanuri, Amilcar ^h  

^a MINISTÉRIO DA SAÚDE   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^e Public Health Lab (LACEN) Brasilia   (Brazil)

^f Central Public Health Laboratory   (Brazil)

^g Health Center Porto   (Brazil)

^h FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79951702447     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.1186/1758-2652-12-20     Document Type: Review

References (30)

1. Antiretroviral treatment in resource-poor settings: the Brazilian experience. Teixeira PR, Vitória MA, Barcarolo J, AIDS 2004 18 Suppl 3 5 7 10.1097/00002030-200406003-00002 (Pubitemid 39037452)
2. Estimating the length of the first antiretroviral therapy regiment durability in Sao Paulo, Brazil. Medeiros R, Diaz RS, Castelo A, Braz J Infect Dis 2002 6 298 304 12585973
3. Characterization of virologic failure after an initially successful 48-week course of antiretroviral therapy in HIV/AIDS outpatients treated in Santos, Brazil. Caseiro MM, Golegã AAC, Etzel A, Diaz RS, Brazilian Journal of Infectious Diseases 2008 12 162 166 10.1590/S1413-86702008000300001 18833397
4. Primary resistance of human immunodeficiency virus type 1 in a reference center in Recife, Pernambuco, Brazil. De Medeiros LB, Lacerda HR, Cavalcanti AM, De Albuquerque M de-F, Mem Inst Oswaldo Cruz 2006 101 845 849 17293977 (Pubitemid 46131332)
5. HIV type 1 subtype C and CB Pol recombinants prevail at the cities with the highest AIDS prevalence rate in Brazil. Brígido LF, Nunes CC, Oliveira CM, Knoll RK, Ferreira JL, Freitas CA, Alves MA, Dias C, Rodrigues R, Research Capacity Program, AIDS Res Hum Retroviruses 2007 23 1579 1586 10.1089/aid.2007.0102 18160017
6. Prevalence of genotypic drug resistance among French patients infected during the year 1999. Chaix ML, Harzic M, Masquelier B, Pellegrin I, Meyer L, Costagliola DI, Rouzioux C, Brun-Vezinet F, Ac11 Resistance Group Cohort, Primo and Primoferon Study Groups, Eighth Conference on Retroviruses and Opportunistic Infections. Chicago 2001 2 4
7. Prevalence of drug resistant mutants and virological response to combination therapy in patients with primary HIV-1 infection. Tamalet C, Pasquier C, Yahi N, Colson P, Martin LP, Lepeu G, Quinson AM, Poizot-Martin I, Dhiver C, Fantini J, J Med Virol 2000 61 181 186 10.1002/(SICI)1096-9071(200006) 61:2<181::AID-JMV2>3.0.CO;2-T 10797372 (Pubitemid 30257241)
8. Frequency of genotypic and phenotypic drug-resistant HIV-1 among therapy-naive patients from the German seroconverter study. Duwe S, Brunn M, Altman D, Hamouda O, Schmidt B, Walter H, Pauli G, Kücherer C, J Acquir Immune Defic Syndr 2001 26 266 273 10.1097/00042560-200103010-00010 11242200 (Pubitemid 32246557)
9. Analysis of prevalence of HIV-1 drug resistance in primary infections in the United Kingdom. UK Collaborative Group on Monitoring the Transmission of HIV Drug Resistance, Br Med J 2001 322 1087 1088 10.1136/bmj.322.7294.1087
10. Antiretroviral drug susceptibility and response to initial therapy among recently HIV-infected subjects in North America. Little SJ, Routy JP, Daar ES, Markowitz M, Collier AC, Koup RA, Conway B, Saag MS, Connick E, Holte S, Corey L, Keiser PH, Mwatha A, Dawson K, Whitcomb JM, Hellmann NS, Richman DD, Antiviral Ther 2001 6 Suppl 1 21
11. HIV-1 drug resistance in newly infected individuals. Boden D, Hurley A, Zhang L, Cao Y, Guo Y, Jones E, Tsay J, Ip J, Farthing C, Limoli K, Parkin N, Markowitz M, JAMA 1999 282 1135 1141 10.1001/jama.282.12.1135 10501116 (Pubitemid 29441957)
12. Drug resistance patterns, genetic subtypes, clinical features, and risk factors in military personnel with HIV-1 seroconversion. Brodine SK, Shaffer RA, Starkey MJ, Tasker SA, Gilcrest JL, Louder MK, Barile A, VanCott TC, Vahey MT, McCutchan FE, Birx DL, Richman DD, Mascola JR, Ann Intern Med 1999 131 502 506 10507958 (Pubitemid 29482393)
13. Primary genotypic and phenotypic HIV-1 drug resistance in recent seroconverters in Madrid. Briones C, Perez-Olmeda M, Rodriguez C, Romero J, Hertogs K, Soriano V, J Acquir Immune Defic Syndr 2001 26 145 150 10.1097/00042560-200102010-00006 11242181 (Pubitemid 32224185)
14. Prevalence of mutations associated with reduced antiretroviral drug susceptibility among human immunodeficiency virus type 1 seroconversters in the United States, 1993-1998. Weinstock H, Respess R, Heneine W, Petropoulos CJ, Hellmann S, Luo CC, Pau CP, Woods T, Gwinn M, Kaplan J, J Infect Dis 2000 182 330 333 10.1086/315686 10882618 (Pubitemid 30497825)
15. Prevalence of mutations associated with antiretroviral drug resistance among HIV-1-infected persons in 10 US cities, 1997-2000. Zaidi I, Weinstock H, Woods T, Petropoulos CJ, Hellmann NS, Luo CC, Pau CP, Woods T, Gwinn M, Kaplan J, Antiviral Ther 2001 6 Suppl 1 118
16. Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain. Puig T, Perez-Olmeda M, Rubio A, Ruiz L, Briones C, Franco JM, Gómez-Cano M, Stuyver L, Zamora L, Alvarez C, Leal M, Clotet B, Soriano V, AIDS 2000 14 727 732 10.1097/00002030-200004140-00012 10807196 (Pubitemid 30229352)
17. Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain. Gomez-Cano M, Rubio A, Puig T, Perez-Olmeda M, Ruiz L, Soriano V, Pineda JA, Zamora L, Xaus N, Clotet B, Leal M, AIDS 1998 12 1015 1020 10.1097/00002030-199809000-00007 9662197 (Pubitemid 28276968)
18. Resistance profiles to antiretroviral drugs in HIV-1 drug-naive patients in Argentina. Kijak GH, Pampuro SE, Avila MM, Zala C, Cahn P, Wainberg MA, Salomon H, Antiviral Ther 2001 6 71 77 (Pubitemid 33704484)
19. Drug resistance mutations among HIV-1 strains from antiretroviral-naive patients in Martinique, French West Indies. Cesaire R, Dos Santos G, Abel S, Bera O, Sobesky G, Cabie A, J Acquire Immune Defic Syndr 1999 22 401 405 (Pubitemid 30030433)
20. Analysis of HIV type 1 protease and reverse transcriptase sequences from Venezuela for drug resistance-associated mutations and subtype classification: A UNAIDS study. Delgado E, Leon-Ponte M, Villahermosa ML, Cuevas MT, Deibis L, Echeverria G, Thomson MM, Pérez-Alvarez L, Osmanov S, Nájera R, AIDS Res Hum Retroviruses 2001 17 753 758 10.1089/088922201750237022 11429115 (Pubitemid 32692413)
21. Brazilian Network for HIV Drug Resistance Surveillance (HIV-BResNet): a survey of chronically infected individuals. Brindeiro RM, Diaz RS, Sabino EC, Morgado MG, Pires IL, Brigido L, Dantas MC, Barreira D, Teixeira PR, Tanuri A, Brazilian Network for Drug Resistance Surveillance, AIDS 2003 17 1063 1069 10.1097/00002030-200305020-00016 12700457 (Pubitemid 36549719)
22. Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update. Bennett DE, Camacho RJ, Otelea D, Kuritzkes DR, Fleury H, Kiuchi M, Heneine W, Kantor R, Jordan MR, Schapiro JM, Vandamme AM, Sandstrom P, Boucher CA, Vijver D van de, Rhee SY, Liu TF, Pillay D, Shafer RW, PLoS ONE 2009 4 4724 10.1371/journal.pone.0004724 19266092
23. A novel sequential sampling technique for the surveillance of transmitted HIV drug resistance by cross-sectional survey for use in low resource settings. Myatt M, Bennett DE, Antivir Ther 2008 13 Suppl 2 37 48 18575190 (Pubitemid 352019088)
24. Drug resistance among chronic HIV-1-infected patients naïve for use of anti-retroviral therapy in Sao Paulo city. Gonsalez CR, Alcalde R, Nishiya A, Barreto CC, Silva FE, de Almeida A, Mendonça M, Ferreira F, Fernandes SS, Casseb J, Duarte AJ, Virus Res 2007 129 87 90 10.1016/j.virusres.2007.06.021 17686543 (Pubitemid 47595356)
25. Prevalence of human immunodeficiency virus drug resistance mutations and subtypes in drug-naive, infected individuals in the army health service of Rio de Janeiro, Brazil. Pires IL, Soares MA, Speranza FA, Ishii SK, Vieira MC, Gouvêa MI, Guimarães MA, de Oliveira FE, Magnanini MM, Brindeiro RM, Tanuri A, J Clin Microbiol 2004 42 426 430 10.1128/JCM.42.1.426-430.2004 14715797 (Pubitemid 38082763)
26. Low prevalence of primary antiretroviral resistance mutations and predominance of HIV-1 clade C at polymerase gene in newly diagnosed individuals from south Brazil. Rodrigues R, Scherer LC, Oliveira CM, Franco HM, Sperhacke RD, Ferreira JL, Castro SM, Stella IM, Brigido LF, Virus Res 2006 116 201 217 10.1016/j.virusres.2005.10.004 16332398 (Pubitemid 43221733)
27. High levels of primary antiretroviral resistance genotypic mutations and B/F recombinants in Santos, Brazil. Sucupira MC, Caseiro MM, Alves K, Tescarollo G, Janini LM, Sabino EC, Castelo A, Page-Shafer K, Diaz RS, AIDS Patient Care STDS 2007 21 116 128 10.1089/apc.2006.0079 17328661 (Pubitemid 46394455)
28. High prevalence of primary antiretroviral resistance among HIV-1-infected adults and children in Bahia, a northeast state of Brazil. Pedroso C, Queiroz AT, Alcântara LC, Drexler JF, Diaz RS, Weyll N, Brites C, J Acquir Immune Defic Syndr 2007 45 251 253 10.1097/QAI.0b013e318050d8b0 17527096 (Pubitemid 46869822)
29. Autochthonous horizontal transmission of a CRF02-AG strain revealed by a human immunodeficiency virus type 1 diversity survey in a small city in inner state of Rio de Janeiro, Southeast Brazil. Eyer-Silva WA, Morgado MG, Mem Inst Oswaldo Cruz 2007 102 809 815 17992366
30. HIV treatment decisions and transmitted drug resistance. Little SJ, Smith DM, Clin Infect Dis 2005 41 233 235 10.1086/431215 15983921 (Pubitemid 40962505)